Boron neutron capture in prostate cancer cells

Applied Radiation and Isotopes

Volumn 70, Issue 1, 2012, Pages 6-12

  Yasui, Linda ^a   Kroc, Thomas ^b   Gladden, Samantha ^a   Andorf, Christine ^a   Bux, Sajit ^a,c   Hosmane, Narayan ^a  

^a NORTHERN ILLINOIS UNIVERSITY   (United States)

^b FERMI NATIONAL ACCELERATOR LABORATORY   (United States)

^c Kishwaukee Community Hospital   (United States)

Author keywords

Boron neutron capture; BPA; Cell survival

Indexed keywords

BPA; CELL KILLING; CELL SURVIVAL; CELLULAR UPTAKE; FERMILAB; HUMAN PROSTATE CANCER CELLS; NEUTRON CAPTURE; PROSTATE CANCER CELLS; RELATIVE BIOLOGICAL EFFECTIVENESS; THERMAL NEUTRON BEAMS;

BORON; BORON COMPOUNDS; DISEASES; GAMMA RAYS; NEUTRONS;

CELLS;

BORON; BORYLPHENYLALANINE; PHENYLALANINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BORON NEUTRON CAPTURE; CANCER CELL; CELL COUNT; CELL GROWTH; CELL KILLING; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; GAMMA RADIATION; GROWTH RATE; HUMAN; HUMAN CELL; NEUTRON; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

BORON NEUTRON CAPTURE THERAPY; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 80955158733     PISSN: 09698043     EISSN: 18729800     Source Type: Journal    
DOI: 10.1016/j.apradiso.2011.07.001     Document Type: Article

References (33)

1. ACS website, 2009. 1 1 Cancer Statistics 2009 Presentation.asp\. http://www.cancer.org/docroot/PRO/contnent/PRO.
2. Barth R.F. Boron neutron capture therapy at the crossroads: challenges and opportunities. Applied Radiation and Isotopes 2009, 67:S3-S6.
3. Barth R.F., Coderre J.A., Vincente M.G.H., Blue T.E. Boron neutron capture therapy of cancer: current status and future prospects. Clincal Cancer Research 2005, 11:3987-4002.
4. Bose R.N., Maurmann L., Mishur R.J., Yasui L., Gupta S., Grayburn W.S., Hofstetter H., Salley T. Non-DNA-binding platinum anticancer agents: cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells. Proceedings of The National Academy of Sciences, USA 2008, 105:18314-18319.
5. Buchholz T.A., Laramore G.E., Wootton P., Livesey J.C., Wilbur D.S., Risler R., Phillips M., Jacky J., Griffin T.W. Enhancement of fast neutron beams with boron neutron capture therapy. Acta Oncologica 1994, 33:307-313.
6. Collis S.J., Swartz M.J., Nelson W.G., DeWeese T.L. Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors. Cancer Research 2003, 63:1550-1554.
7. Corderre J.A., Chanana A.D., Joel D.D., Elowitz E.H., Micca P.L., Nawrocky M.M., Chadha M., Gebbers J-O., Shady M., Peress N.S., Slatkin D.N. Biodistribution of boronophenylalanine in patients with glioblastoma multiform: boron concentration correlates with tumor cellularity. Radiation Research 1998, 149:163-170.
8. Dai Y., Liu M., Tang W., DeSanto J., Burstein E., Davis M., Pienta K., Lawrence T., Xu L. Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis. Clinical Cancer Research 2008, 14:7701-7710.
9. Detta A., Cruickshank G.S. l-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors. Cancer Research 2009, 69:2126-2132.
10. Elkind, M.M., Whitmore, G.F., 1967. In: The Radiobiology of Cultured Mammalian Cells. Gordon and Breach, Science Publishers Inc, London.
11. Greco C. Particle therapy in prostate cancer: a review. Prostate Cancer and Prostatic Diseases 2007, 10:323-330.
12. Harling O.K., Riley K.J. Fission reactor neutron sources for neutron capture therapy-a critical review. Journal of Neuro-Oncology 2003, 62:7-17.
13. Hall E.J., Novak J.K., Kelerer A.M., Rossi H.H., Marino S., Goodmans L.J. RBE as a function of neutron energy. I. Experimental observations. Radiation Research 1975, 64:243-255.
14. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics. CA Cancer Journal Clinical 2007, 57:43-66.
15. Kroc, T.K., 2009. Preliminary Investigations of Monte Carlo Simulations of Neutron Energy and LET Spectra for Fast Neutron Therapy Facilities. http://lss.fnal.gov/archive/2009/conf/fermilab-conf-09-133-ad.pdf.
16. Lavaf A., Fu S., Peters S., Hou Y-N., Rosenstein B.S., Kao J. ATM phosphorylation kinetics as a biological reporter of cellular radiosensitivity. Journal of Cancer Molecules 2009, 5:9-14.
17. Nemoto H., Cai J., Asao N., Iwamoto S., Yamamoto Y. Synthesis and biological properties of water- soluble p-boronophenylalanine derivatives. Relationship between water solubility, cytotoxicity and cellular uptake. Journal of Medicinal Chemistry 1995, 38:1673-1678.
18. National Nuclear Data Center, 2011. Sigma Evaluated Nuclear Data File Retrieval and Plotting page. The Cross Section Library is the ENDF/B-VII.0. http://www.nndc.bnl.gov/sigma/.
19. Pollack A., Hanlon A., Horwitz E.M., Feigenberg S., Uzzo R.G., Price R.A. Radiation therapy dose escalation for prostate cancer a rationale for IMRT. World Journal of Urology 2003, 21:200-208.
20. Ross M.A., DeLuca P.M., Jones D.T.L., Lennox A., Maughan R.L. Calculated fluence spectra at neutron therapy facilities. Radiation Protection Dosimetry 1997, 70:481-484.
21. Saier M.J., Daniels G.A., Boerner P., Lin J Neutral amino acid transporter systems in animal cells: potential targets of oncogene action and regulators of cellular growth. Journal of Membrane Biology 1998, 104:1-20.
22. Sakata T., Ferdous G., Tsuruta T., Satoh T., Baba S., Muto T., Ueno A., Kanai Y., Endou H., Okayasu I. l-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer. Pathology International 2009, 59:7-18.
23. Salt C., Lennox A., Takagaki M., Maguire J., Hosmane N. Boron and gadolinium neutron capture therapy. Russian Chemical Bulletin 2004, 53:1871-1888.
24. Sjoberg S., Carlsson J., Ghaneolhosseini H., Gedda L., Hartman T., Malmquist J., Naeslund C., Olsson P., Tjarks W. Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy. Journal of Neuro-Oncology 1997, 33:41-52.
25. Schinazi, R.F., Keane, T.E., Liotta, D.C., 1997. Treatment of Urogenital Cancer with Boron Neutron Capture Therapy. US patent number 5,599,796.
26. Stelzer K.J., Lindsley K.L., Cho P.S., Laramore G.E., Griffin T.W. Fast neutron radiotherapy: the University of Washington experience and potential use of concomitant boost with boron neutron therapy. Protection Dosimetry Radiation 1997, 70:471-475.
27. Sweezey J., Hertel N., Lennox A. Filter, collimator and moderating material to achieve boron neutron capture enhanced fast neutron therapy. Radiation Protection Dosimetry 2005, 116:470-474.
28. Van Dam J., Beauduin M., Gregoire V., Gueulette J., Laublin G., Wambersie A. Variation of neutron RBE as a function of energy for different biological systems: a review. Radition Protection Dosimetry 1992, 44:41-44.
29. Wang J.Z., Rhee J.G., Shi P., Stewart R.D., Li X.A. In vitro determination of radiation sensitivity parameters for DU-145 prostrate cancer cells. International Journal of Radiation Biology 2008, 84:515-522.
30. Wang, Z., 2006. Design of a Boron Neutron Capture Enhanced Fast Neutron Therapy Assembly. Ph.D. Dissertation. G.W. Woodruff School of Mechanical Engineering. Georgia Institute of Technology.
31. Wittig A., Sauerwein W.A., Coderre J.A. Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitro. Radiation Research 2000, 153:173-180.
32. Yasui L.S., Andorf C., Schneider L., Kroc T., Lennox A., Saroja K.R. Gadolinium neutron capture in glioblastoma multiforme cells. International Journal of Radiation Biology 2008, 84:1130-1139.
33. 125I-estrogen decays in estrogen receptor expressing human breast cancer cells. Radiation Research 2001, 155:328-334.